Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
NantHealth, Inc. NH
$3.00
+$0.21 (7.14%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
21954405.00000000
-
week52high
10.20
-
week52low
1.24
-
Revenue
67002000
-
P/E TTM
-1
-
Beta
1.83356400
-
EPS
-9.93000000
-
Last Dividend
0.00000000
-
Next Earnings Date
03 мая 2023 г. в 10:59
Описание компании
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Canaccord Genuity | Buy | Buy | 17 ноя 2017 г. |
| Jefferies | Buy | Buy | 23 авг 2017 г. |
| Canaccord Genuity | Buy | Buy | 21 авг 2017 г. |
| Cantor Fitzgerald | Overweight | 06 янв 2017 г. | |
| First Analysis | Overweight | Overweight | 27 июн 2016 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| BLASZYK MICHAEL D | A | 100000 | 100000 | 09 июн 2022 г. |
| Wise Deanna L. | A | 100000 | 100000 | 09 июн 2022 г. |
| CALHOUN KIRK K | A | 100000 | 100000 | 09 июн 2022 г. |
| Louks Ronald Allen | D | 225857 | 9200 | 13 сент 2021 г. |
| Louks Ronald Allen | A | 235057 | 9200 | 13 сент 2021 г. |
| Louks Ronald Allen | D | 225857 | 9200 | 13 сент 2021 г. |
| Louks Ronald Allen | A | 235057 | 9200 | 13 сент 2021 г. |
| Louks Ronald Allen | D | 510662 | 9200 | 13 сент 2021 г. |
| Louks Ronald Allen | A | 233177 | 7320 | 10 сент 2021 г. |
| Louks Ronald Allen | D | 225857 | 7320 | 10 сент 2021 г. |
Новостная лента
NantHealth, Inc. (NH) Q3 2022 Earnings Call Transcript
Seeking Alpha
06 ноя 2022 г. в 07:04
NantHealth, Inc. (NASDAQ:NH ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Ron Louks - Chief Operating Officer Bob Petrou - Chief Financial Officer Conference Call Participants Robert Jaffe Welcome everyone and thank you for joining us today to discuss NantHealth's 2022 Third Quarter Financial Results. On the call today are Ron Louks, Chief Operating Officer; and Bob Petrou, our Chief Financial Officer.
NantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3
Business Wire
31 окт 2022 г. в 16:50
MORRISVILLE, N.C.
NantHealth, Inc. (NH) Management on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
06 авг 2022 г. в 18:45
NantHealth, Inc. (NASDAQ:NH ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Ron Louks - Chief Operating Officer Bob Petrou - Chief Financial Officer Robert Jaffe Welcome, everyone, and thank you for joining us today to discuss NantHealth's 2022 second quarter financial results. On the call today are Ron Louks, Chief Operating Officer; and Bob Petrou, our Chief Financial Officer.